Source: Eur Respir Rev, 31 (163) 210150; 10.1183/16000617.0150-2021



Rating:

Share or cite this content

Citations should be made in the following way:
David J. Jackson, Praveen Akuthota, Florence Roufosse. Eosinophils and eosinophilic immune dysfunction in health and disease. Eur Respir Rev, 31 (163) 210150; 10.1183/16000617.0150-2021

Member's Comments

No comment yet.

Related content which might interest you: Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease Source: Eur Respir Monogr 2022; 95: 219-237 Year: 2022 Lymphoid interstitial pneumonia should be suspected in children with autoimmune disease and immune deficiency Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021 Neutrophils in chronic inflammatory airway diseases: can we target them and how? Source: Eur Respir J 2010; 35: 467-469 Year: 2010 Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Monocytes and macrophages in chronic sarcoidosis pathology Source: Eur Respir J, 54 (5) 1901626; 10.1183/13993003.01626-2019 Year: 2019 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 The role of polymorphonuclear neutrophil leucocytes in the development of bronchial hyperreactivity in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 Microbes mediated host innate immune response in idiopathic pulmonary fibrosis Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Immune system dysregulation in chronic lung disease Source: Eur Respir J 2011; 38: 500-501 Year: 2011 Immune status in patients with bronchial asthma exacerbation and comorbide digestive system diseases Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Benralizumab for severe asthma associated with extra-airway eosinophilic diseases Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 The innate immune function of airway epithelial cells in inflammatory lung disease Source: Eur Respir J 2015; 45: 1150-1162 Year: 2015 Bronchiectasis associated with inflammatory bowel disease Source: Eur Respir Mon 2011; 52: 163-177 Year: 2011 Relevance of innate immune responses to chronic airway diseases Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences Year: 2008